Long Covid Antibody Spectrum Test
Attomarker is developing a breakthrough diagnostic solution for Long Covid: the Long Covid Antibody Spectrum Test. The test is expected to receive UKCA Mark approval imminently, and will represent a significant step in helping to understand why an individual has Long Covid and what therapeutic options may provide benefit.
Join the Movement for Answers in Long Covid
We’re inviting individuals impacted by Long Covid, healthcare providers, and researchers to join us on this journey. By staying informed and connected with our work, you can be part of the solution to this global health challenge.
How you can get involved:
Subscribe for Updates
Sign up to be the first to hear about our latest developments, including the UKCA Mark approval of the Long Covid Antibody Spectrum Test.
Participate in Research
Spread the Word
Keep Updated
Check out our LinkedIn for the latest updates on Attomarker including our Company Announcements, Investor Announcement and product launches.